Evidence map›Paper›PMID 41884657›Full record

ArticleClinical parkinsonism & related disorders2026

Chorea-acanthocytosis presenting with epilepsy at onset harboring novel compound heterozygous

Mitsuyoshi Tamura, Shogo Furukawa, Masahiro Namiki, Yukiko Ozawa, Yuka Urata, Masayuki Nakamura, Mitsuru Watanabe, Hideki Oshima, Toshiki Obuchi, Tadashi Ichikawa and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical parkinsonism & related disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mitsuyoshi TamuraDepartment of Neurology, Japanese Red Cross Narita Hospital, Chiba, Japan.
Shogo FurukawaDepartment of Neurology, Japanese Red Cross Narita Hospital, Chiba, Japan.
Masahiro NamikiDepartment of Neurology, Japanese Red Cross Narita Hospital, Chiba, Japan.
Yukiko OzawaDepartment of Neurology, Japanese Red Cross Narita Hospital, Chiba, Japan.
Yuka UrataDepartment of Psychiatry, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Masayuki NakamuraDepartment of Psychiatry, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Mitsuru WatanabeDepartment of Neurosurgery, Saitama Rehabilitation Center, Saitama, Japan.
Hideki OshimaDepartment of Neurosurgery, Saitama Rehabilitation Center, Saitama, Japan.
Toshiki ObuchiDepartment of Neurosurgery, Saitama Rehabilitation Center, Saitama, Japan.
Tadashi IchikawaDepartment of Neurology, Saitama Rehabilitation Center, Saitama, Japan.
Yuriko KikkawaDepartment of Neurology, Japanese Red Cross Narita Hospital, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41884657
PMCPMC13011226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.